CardioVascular BioTherapeutics (fka CVBT)

[walhall]

CVBT and disinformation, fraud, and bankruptcy, Part 2

I’m in absolute awe of the Cardiovascular Biotherapeutics (CVBT) disinformation campaign in full throttle here. Is this being waged by CVBT’s leadership, or does CVBT have nothing to do with it? We’ll never know, but I personally believe it’s the former.

Let’s take a look at facts on the ground which can not be challenged.

At the 2019 annual shareholders meeting, a number of shareholders (including myself) asked CVBT the following three questions during the Q&A period, and I publicly posted them on this message board several weeks in advance of the meeting so CVBT’s leadership would have notice these questions were coming and could prepare answers, and so there would be a public record of the questions being asked in the first place:

1. Since 2016 through today, how much in total equity has CVBT raised? At what price(s) per share? Of the total amount raised, how much came from investors others than CVBT’s CEO Calvin Wallen?

2. At last year’s shareholder meeting, CVBT stated that the Phase II heart clinical trial will be starting in 2019, and the peripheral artery disease trial will be starting in late 2019 or 2020. Yes or no, does CVBT have all the required funding in-hand TODAY to conduct these trials and run the company during this period? If the answer is no, how much in funding is still needed?

3. There are rumors on the message board for many months now that CVBT will be going public again “soon.” Yes or no, will CVBT be going public in 2019?

In spite of multiple shareholders asking these questions during the Q&A period, CVBT refused to answer ANY of them at the annual meeting (to no one’s surprise—CVBT’s leadership has been anything but forthcoming with information since Calvin Wallen’s hostile takeover succeeded).

Now let me quote exactly what CVBT’s CEO Calvin Wallen III said in indirect response to these questions during the Q&A period at the 2019 shareholders meeting: “We would like to tell everyone as much as we can. But the more we speak to, the more we expose ourselves to other entities pirating our science and our work. There are certain things we are just not allowed to talk about. Therefore we have to hold those things close to ourselves.”

CVBT’s CEO publicly stated CVBT is not going to answer questions nor divulge information beyond what was revealed at the shareholder’s meeting. And in my opinion, all that was revealed at the shareholder’s meeting of value was that CVBT’s clinical trial and manufacturing timelines have slipped by 12 months from the last time Calvin Wallen presented timelines, which means in the last 12 months no progress was made relative to what Mr. Wallen indicated at the 2018 shareholders meeting.

So now let’s review what’s being anonymously indicated on this message board. Posting after posting indicates how Calvin Wallen and CVBT’s board encourage and take calls from “shareholders” and then CVBT’s leadership allegedly reveals in these calls all sorts of “information” that is then publicly shared here (anonymously of course) yet which CVBT would not PUBLICLY reveal at the shareholders meeting just a few months ago. Of the 2 shareholders I personally know who have placed calls to Calvin Wallen, not one has received a return phone call. Unlucky perhaps?

Further, in spite of CVBT’s CEO PUBLICLY STATING at the shareholder’s meeting that no additional information would be provided, lo and behold it’s being anonymously “revealed” here. How credible is that? And if anyone believes this (dis)information, could you please provide me with their email address so the widow of General Kwami Niyanzadugu of Tanzania can contact them seeking their assistance retrieving $50 million that’s stashed away in a secret bank account in Switzerland?

I’ll trust logic and common sense every time. And the truth is, hard facts on the ground which can not be denied are 100% at odds with anonymous “information” being posted on this message board in recent weeks, bragging about large sums of money being allegedly raised, an alleged CVBT balance sheet which is allegedly solven rather than grossly insolvent (yet CVBT refuses to release an audited financial statement), alleged investment banks allegedly swooning over CVBT, an alleged IPO that is just around the corner (right), alleged partnering deals being allegedly done, alleged manufacturing timelines that are internally inconsistent and illogical, etc.

It’s impressive in its obviousness.

Here is a link to Part 1 of this series/extended discussion. More is to follow.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865

And here’s the latest update on the upcoming fraud trial of CVBT’s CEO, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915

And here's how bad things have gotten:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150504898